A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge

Archives of Virology

Volumn 153, Issue 12, 2008, Pages 2215-2223

  De Paula, Sérgio Oliveira ^a   Lima, Danielle Malta ^b   De Oliveira França, Rafael Freitas ^b   Gomes Ruiz, Alessandra Cristina ^b   Da Fonseca, Benedito Antônio Lopes ^b  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DENGUE VACCINE; DNA VACCINE; E PROTEIN, DENGUE VIRUS TYPE 3; PRM PROTEIN, DENGUE VIRUS TYPE 3; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CELL PROLIFERATION; CERCOPITHECUS; DENGUE; DENGUE VIRUS; FEMALE; GENETICS; HELA CELL; HUMAN; IMMUNOLOGY; METABOLISM; MORTALITY; MOUSE; SERODIAGNOSIS; T LYMPHOCYTE; TUMOR CELL LINE; VERO CELL;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CYTOKINES; DENGUE; DENGUE VACCINES; DENGUE VIRUS; FEMALE; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINES, DNA; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

ANIMALIA; DENGUE VIRUS TYPE 3; MUS;

EID: 58149302857     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-008-0250-3     Document Type: Article

References (33)

1. G Ada 2001 Vaccines and vaccination N Engl J Med 345 1042 1053
2. N Bhamarapravati Y Sutee 2000 Live attenuated tetravalent dengue vaccine Vaccine 18 44 47
3. PJ Blair l Koche K Raviprakash C Guevara M Salazar SJ Wu JG Olson KR Porter 2006 Evaluation of immunity and protective efficacy of a dengue-3 premembrane and envelope DNA vaccine in Aotus nancymae monkeys Vaccine 24 1427 1432
4. Burke DS, Monath TP (2001) Flavivirus. In: Knipe DM, Howley PM (eds) Fields virology, 4th edn. Williams & Willkins, Philadelphia, pp 1043-1125
5. RO Cazionez BAL Fonseca 2001 Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice Vaccine 19 648 654
6. TJ Chambers TF Tsai Y Pervikov TP Monath 1997 Vaccine development against dengue and Japanese encephalitis: report a World Health Organization meeting Vaccine 15 1494 1502
7. WD Crill RT Roehrig 2001 Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells J Virol 75 7769 7773
8. PJ Delves IM Roitt 2000 The immune system N Engl J Med 343 37 49
9. T Dharakul I Kurane N Bhamarapravati S Yoksan DW Vaughn CH Hoke FA Ennis 1994 Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine J Infect Dis 170 27 33
10. R Edelman SS Wasserman SA Bodison RJ Putnak KH Eckels D Tang N Kanesa-Thasan DW Vaughn BL Innis W Sun 2004 Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine Am J Trop Med Hyg 70 336
11. Fauquet CM, Mayo CM, Maniloff J, Desselberger U, Ball LA (2005) Virus taxonomy eight report of the international committee on taxonomy of viruses. Elsevier Academic Press, California
12. B Fonseca S Pincus RE Shope E Paoletti PW Mason 1994 Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice Vaccine 12 279 285
13. RV Gibbons DW Vaughn 2002 Dengue: an escalating problem BMJ 324 1563 1566
14. DJ Gubler 1998 Dengue and dengue hemorrhagic fever Clin Microbiol Rev 11 480 496
15. F Guirakhoo KV Pugachev ZX Zhang G Myers I Levenbook K Draper J Lang S Ocran F Itchell M Parsons N Brown S Brandler C Fournier B Barrere F Rizvi A Travassos R Nichols D Trent TP Monath 2004 Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates J Virol 78 4761 4775
16. CS Hahn S Lusting EG Strauss JH Strauss 1988 Western equine encephalitis virus is a recombinant virus Proc Natl Acad Sci USA 85 5997 6001
17. SB Halstead 1988 Pathogenesis of dengue: challenges to molecular biology Science 239 476 481
18. FX Heinz K Stiasny G Puschner-Auer H Holzman SL Allison CW Mandl C Kunz 1994 Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM Virology 198 109 117
19. S Jaiswa N Khanna S Swaminathan 2004 High-level expression and one-step purification of recombinant dengue virus type-2 envelope domain III protein in Escherichia colli Protein Expr Purif 33 80 91
20. BM Kaufman PL Summers DR Dubois KH Eckels 1987 Monoclonal antibodies against dengue-2 virus E glycoprotein protect mice against lethal dengue infection Am J Trop Med Hyg 36 427 434
21. E Konishi A Fujii 2002 Dengue type 2 virus subviral extracellular particles produced by a stable transfected mammalian cell line and their evaluation for a subunit vaccine Vaccine 20 1058 1067
22. Konishi E, Yamaoka M, Khin-Sane-Win, Kurane I, Mason PW (1998) Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding JE virus premembrane and envelope genes. J Virol 72: 4925-4930
23. I Kurane RA Meage FA Ennis 1989 Dengue virus-specific human T cell clones serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity J Exp Med 170 763 775
24. B Lin CR Parrish JM Murray PJ Wright 1994 Localization of a neutralization epitope on the envelope protein of dengue virus type 2 Virology 202 885 890
25. K Raviprakash TJ Kochel D Ewing M Simmons I Phillips CG Hayes KR Porter 2000 Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein Vaccine 18 2426 2436
26. JG Rigau-Perez CG Clark DJ Gubler P Reiter EJ Sanders AV Vorndam 1998 Dengue and dengue haemorrhagic fever Lancet 352 971 977
27. AL Rothman N Kanesa-Thasan K West J Janus JF Saluzzo FA Ennis 2001 Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine Vaccine 19 4694 4699
28. PK Russell A Nisalak 1967 Dengue virus identification by the plaque reduction neutralization test J Immunol 99 291 296
29. SJ Seligman EA Gould 2004 Live flavivirus vaccines: reasons for caution Lancet 363 2073 2075
30. RB Tesh 1979 A method for the isolation and identification of dengue viruses, using mosquito cell cultures Am J Trop Med Hyg 28 1053 1059
31. T Trirawatanapong B Chandran R Putnak R Padmanabhan 1992 Mapping of a region of dengue virus type 2 glycoprotein required for binding by a neutralizing monoclonal antibody Gene 16 139 150
32. SS Twiddy EC Holmes 2003 The extent of homologous recombination in members of the genus Flavivirus J Gen Virol 84 429 440
33. S-F Wu C-L Liao Y-L Lin C-T Yeh L-H Chen Y-F Huang H-Y Chou J-L Huang M-F Shaio H-K Sytwu 2003 Evaluation of a protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice Vaccine 21 3919 3929